发明名称 |
Agent for improving vesicourethral dyssynergia |
摘要 |
This invention is directed to an ameliorating agent for a disease based on vesicourethral dyssynergia, comprising, as an active ingredient, 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexene-1-one, a salt thereof, or a solvate thereof. The disease based on vesicourethral dyssynergia is any of dysuria accompanying a lifestyle-related disease (such as diabetic dysuria), idiopathic dysuria, dysuria after pelvic surgery, dysuria accompanying spinal cord injury, dysuria accompanying spinal canal stenosis, dysuria accompanying benign prostatic hypertrophy, dysuria accompanying high-pressure voiding/high-pressure urine storage, neurogenic or nonneurogenic lower urinary tract symptoms (LUTS), detrusor sphincter dyssynergia, and detrusor bladder neck dyssynergia. |
申请公布号 |
US9271948(B2) |
申请公布日期 |
2016.03.01 |
申请号 |
US201414496281 |
申请日期 |
2014.09.25 |
申请人 |
Taiho Pharmaceutical Co., Ltd. |
发明人 |
Hayashi Yukio;Hakozaki Atsushi |
分类号 |
A61K31/122 |
主分类号 |
A61K31/122 |
代理机构 |
Rothwell, Figg, Ernst & Manbeck, P.C. |
代理人 |
Rothwell, Figg, Ernst & Manbeck, P.C. |
主权项 |
1. A method for treating detrusor sphincter dyssynergia in a patient in need thereof, comprising the step of administering a therapeutically effective amount of 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexene-1-one, a salt thereof, or a solvate thereof to said patient. |
地址 |
Tokyo JP |